Tenvir-EM (Emtricitabine & Tenofovir) - HIV Pre-Exposure Prophylaxis

Tenvir-Em 200/300 Tab(Emtricitabine + Tenofovir disoproxil fumarate)         

Tenvir-EM combines Emtricitabine (200mg) and Tenofovir Disoproxil Fumarate (300mg) to offer effective pre-exposure prophylaxis (PrEP) for HIV prevention. Widely trusted in the management of HIV and reducing the risk of infection, Tenvir-EM is recommended for high-risk populations. The medication inhibits HIV replication, helping prevent HIV transmission for those at risk in countries with high HIV prevalence, like South Africa, Uganda, Tanzania, and Zimbabwe.

Key Benefits:

• Pre-Exposure Prophylaxis (PrEP) for HIV prevention.
• Trusted combination therapy with Emtricitabine and Tenofovir.
• Proven efficacy in reducing HIV infection risk in high-risk populations.

Usage: Take one tablet daily as prescribed by your healthcare provider.

Precautions: Regular HIV testing is recommended before and during the use of PrEP. Do not use if you are HIV-positive without consulting a healthcare provider.

Substitutes Available

Tofocom 200/300 mg Tab(by Alkem Laboratories Ltd.) 

Tenof EM 200/300 mg Tab(by Hetero Drugs Ltd.)

Ricovir EM 200/300 mg Tab(by Mylan Pharmaceuticals)

Tavin EM 200/300 mg Tab(by Emcure Pharmaceuticals)

Tentide EM 200/300 mg Tab(by Sun Pharmaceuticals)